Skip to main content

Peer Review reports

From: The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress

Original Submission
24 Mar 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
11 May 2016 Editorially accepted
19 May 2016 Article published 10.1186/s12885-016-2354-6

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us